Skip to content

CHECKED

Companies Insolvencies Sectors Watchlist Alerts API

MedImprove

Mortsel ·KBO/BCE: BE 0758.914.241

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Badge

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Answers from Checked AI. Not legal advice.

Metric	This company	Sector median	Position in the sector
Solvency	13.3%	46.6%	better than 30% of 76 sector peers
Net result	€176k	€22k	better than 91% of 75 sector peers
Equity	€301k	€61k	better than 80% of 76 sector peers
Gross operating margin	€616k	€49k	better than 95% of 72 sector peers
Total assets	€2.26M	€228k	better than 86% of 76 sector peers

Fiscal year	2025
Revenue	-
EBITDA	€409k
Net profit	€176k
Cash flow	€309k
Staff costs	€195k
Income taxes	€50k
Dividends	€150k
Total assets	€2.26M
Equity	€301k
Debt	€1.96M
of which ≤ 1y	€795k
of which > 1y	€1.17M
Working capital	€-68k
Employees (FTE)	3.3

	2025
Current ratio	0.91
Quick ratio	0.91
Working capital ratio	-3.0%
Solvency	13.3%
Debt / equity	6.51
Long-term debt ratio	3.87
Interest coverage	8.26
Gross margin	-
Net margin	-
ROA	7.8%
ROE	58.6%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€2.26M
Fixed assets	21/28	€1.54M
Tangible fixed assets	22/27	€1.26M
Financial fixed assets	28	€275k
Current assets	29/58	€726k
Amounts receivable within one year	40/41	€464k
Cash & bank	54/58	€252k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€2.26M
Equity	10/15	€301k
Contributions / capital	10/11	€160k
Reserves	13	€141k
Accumulated profits (losses)	14	€0
Amounts payable	17/49	€1.96M
Amounts payable after one year	17	€1.17M
Amounts payable within one year	42/48	€795k
Trade debts payable within one year	44	€418k
Income statement
Gross operating margin	9900	€616k
Operating result	9901	€276k
Financial charges	65	€49k
Result before taxes	9903	€227k
Income taxes	67/77	€50k
Net result for the period	9904	€176k
Result to be appropriated	9905	€176k

NACE primary	Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form	Private limited company(610)
Incorporation	30-11-2020
Status	Active
Postal code	2640

MedImprove

MedImprove

Summary

Conclusion

Trust signals

Administrative Flags

Bankruptcy probability (12 mo)

Financials

Annual accounts & ratios

Health barometer

Directors

Directors & mandates

Insolvency mandates

Legal Structure

Structure & network

Connections & network

Locations & real estate

Registered office

Establishment units

Real-estate footprint

Analysis

Snowflake analysis

Ask AI about this company

AI due-diligence brief

Credit advice

Similar

Similar companies

Company registry

Company registry (CBE)